Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
KEM Hospital Research Centre, Pune, India.
J Glob Health. 2021 Jun 19;11:04026. doi: 10.7189/jogh.11.04026.
Chronic respiratory diseases (CRDs) contribute significantly towards the global burden of disease, but the true prevalence and burden of these conditions in adults is unknown in the majority of low- and middle-income countries (LMICs). We aimed to identify strategies - in particular the definitions, study designs, sampling frames, instruments, and outcomes - used to conduct prevalence surveys for CRDs in LMICs. The findings will inform a future RESPIRE Four Country ChrOnic Respiratory Disease (4CCORD) study, which will estimate CRD prevalence, including disease burden, in adults in LMICs.
We conducted a scoping review to map prevalence surveys conducted in LMICs published between 1995 and 2018. We followed Arksey and O'Malley's six-step framework. The search was conducted in OVID Medline, EMBASE, ISI Web of Science, Global Health, WHO Global Index Medicus and included three domains: CRDs, prevalence and LMICs. After an initial title sift, eight trained reviewers undertook duplicate study selection and data extraction. We charted: country and populations, random sampling strategies, CRD definitions/phenotypes, survey procedure (questionnaires, spirometry, tests), outcomes and assessment of individual, societal and health service burden of disease.
Of 36 872 citations, 281 articles were included: 132 from Asia (41 from China). Study designs were cross-sectional surveys (n = 260), cohort studies (n = 11) and secondary data analysis (n = 10). The number of respondents in these studies ranged from 50 to 512 891. Asthma was studied in 144 studies, chronic obstructive pulmonary disease (COPD) in 112. Most studies (100/144) based identification of asthma on symptom-based questionnaires. In contrast, COPD diagnosis was typically based on spirometry findings (94/112); 65 used fixed-ratio thresholds, 29 reported fixed-ratio and lower-limit-of-normal values. Only five articles used the term 'phenotype'. Most studies used questionnaires derived from validated surveys, most commonly the European Community Respiratory Health Survey (n = 47). The burden/impact of CRD was reported in 33 articles (most commonly activity limitation).
Surveys remain the most practical approach for estimating prevalence of CRD but there is a need to identify the most predictive questions for diagnosing asthma and to standardise diagnostic criteria.
慢性呼吸道疾病(CRD)对全球疾病负担的影响巨大,但在大多数中低收入国家(LMICs),这些疾病的真实流行率和负担尚不清楚。我们旨在确定在 LMICs 中进行 CRD 患病率调查所使用的策略 - 特别是定义、研究设计、抽样框架、工具和结果。研究结果将为未来的 RESPIRE 四个国家慢性呼吸道疾病(4CCORD)研究提供信息,该研究将估计 LMICs 中成人 CRD 的患病率,包括疾病负担。
我们进行了范围综述,以绘制 1995 年至 2018 年期间在 LMICs 中进行的患病率调查。我们遵循了 Arksey 和 O'Malley 的六步框架。搜索在 OVID Medline、EMBASE、ISI Web of Science、全球健康、世界卫生组织全球索引 Medicus 中进行,包括三个领域:CRD、患病率和 LMICs。在初步标题筛选后,八名经过培训的评审员进行了重复的研究选择和数据提取。我们绘制了以下内容:国家和人群、随机抽样策略、CRD 定义/表型、调查程序(问卷、肺量计、测试)、结果以及个人、社会和卫生服务疾病负担的评估。
在 36872 条引文中,有 281 篇文章被纳入:其中 132 篇来自亚洲(41 篇来自中国)。研究设计为横断面调查(n=260)、队列研究(n=11)和二次数据分析(n=10)。这些研究的受访者人数从 50 到 512891 人不等。144 项研究中研究了哮喘,112 项研究中研究了慢性阻塞性肺疾病(COPD)。大多数研究(144 项中的 100 项)基于基于症状的问卷来确定哮喘。相比之下,COPD 诊断通常基于肺量计结果(112 项中的 94 项);65 项使用固定比例阈值,29 项报告固定比例和下限正常值。只有五篇文章使用了“表型”一词。大多数研究使用源自已验证调查的问卷,最常用的是欧洲社区呼吸健康调查(n=47)。有 33 篇文章报告了 CRD 的负担/影响(最常见的是活动受限)。
调查仍然是估计 CRD 患病率最实用的方法,但需要确定最能预测哮喘诊断的问题,并使诊断标准标准化。